FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4360804105> ?p ?o ?g. }

• W4360804105 endingPage "2854" @default.
• W4360804105 startingPage "2839" @default.
• W4360804105 abstract "Th17 (T-helper 17) cells subtype of non-T2 (non-type 2) asthma is related to neutrophilic infiltration and resistance to inhaled corticosteroids (ICS), so is also known as severe asthma. Methyl-CpG binding domain protein 2 (MBD2) regulates the differentiation of the Th17 cells, tending to show a therapeutic target in severe asthma. miR-146a-3p is associated with anti-inflammatory characteristics and immunity. Moreover, bioinformatic analysis showed that MBD2 may be a target gene of miR-146a-3p. However, the role of miR-146a-3p in the differentiation of Th17 cells via MBD2 in severe asthma remains unknown. Here, we aimed to explore how miR-146a-3p interacts with MBD2 and affects the differentiation of Th17 cells in severe asthma. First, we recruited 30 eligible healthy people and 30 patients with severe asthma to detect the expression of miR-146a-3p in peripheral blood mononuclear cells (PBMCs) by qRT-PCR. Then, we established a HDM/LPS (house dust mite/lipopolysaccharide) exposure model of bronchial epithelial cells (BECs) to evaluate the expression of miR-146a-3p, the interaction between miR-146a-3p and MBD2 using western blot and luciferase reporter analysis and the effect of miR-146a-3p regulated Th17 cells differentiation by flow cytometry in BECs in vitro. Finally, we constructed a mouse model of Th17 predominant neutrophilic severe asthma to assess the therapeutic potential of miR-146a-3p in severe asthma and the effect of miR-146a-3p regulated Th17 cells differentiation via MBD2 in vivo. Decreased miR-146a-3p expression was noted in severe asthma patients, in the BECs and in the animal severe asthma models. Moreover, we demonstrated that miR-146a-3p suppressed Th17 cells differentiation by targeting the MBD2. miR-146a-3p overexpression significantly reduced airway hyperresponsiveness, airway inflammation and airway mucus secretion, while also inhibiting Th17 cells response in vivo, which relieved severe asthma. By targeting MBD2 to suppress Th17 cells differentiation, miR-146a-3p provides a potential novel therapeutic for Th17 predominant neutrophilic severe asthma." @default.
• W4360804105 created "2023-03-25" @default.
• W4360804105 creator A5005572572 @default.
• W4360804105 creator A5007704090 @default.
• W4360804105 creator A5008659449 @default.
• W4360804105 creator A5034054749 @default.
• W4360804105 creator A5034673563 @default.
• W4360804105 creator A5039733933 @default.
• W4360804105 creator A5043274812 @default.
• W4360804105 creator A5044462846 @default.
• W4360804105 creator A5053976378 @default.
• W4360804105 creator A5054625774 @default.
• W4360804105 creator A5055518755 @default.
• W4360804105 creator A5056830118 @default.
• W4360804105 creator A5058548425 @default.
• W4360804105 creator A5077267588 @default.
• W4360804105 creator A5077986501 @default.
• W4360804105 creator A5087322661 @default.
• W4360804105 date "2023-03-24" @default.
• W4360804105 modified "2023-10-18" @default.
• W4360804105 title "miR-146a-3p as a potential novel therapeutic by targeting MBD2 to mediate Th17 differentiation in Th17 predominant neutrophilic severe asthma" @default.
• W4360804105 cites W1046554971 @default.
• W4360804105 cites W1829298281 @default.
• W4360804105 cites W1840711934 @default.
• W4360804105 cites W1982967230 @default.
• W4360804105 cites W1986788841 @default.
• W4360804105 cites W1993997407 @default.
• W4360804105 cites W1995648886 @default.
• W4360804105 cites W2007031153 @default.
• W4360804105 cites W2017549908 @default.
• W4360804105 cites W2021701428 @default.
• W4360804105 cites W2024301198 @default.
• W4360804105 cites W2031613673 @default.
• W4360804105 cites W2035908500 @default.
• W4360804105 cites W2040875973 @default.
• W4360804105 cites W2041349546 @default.
• W4360804105 cites W2047516222 @default.
• W4360804105 cites W2047622007 @default.
• W4360804105 cites W2055515566 @default.
• W4360804105 cites W2071188966 @default.
• W4360804105 cites W2096388504 @default.
• W4360804105 cites W2098276532 @default.
• W4360804105 cites W2099802544 @default.
• W4360804105 cites W2105549148 @default.
• W4360804105 cites W2106715003 @default.
• W4360804105 cites W2114589605 @default.
• W4360804105 cites W2118842534 @default.
• W4360804105 cites W2124890594 @default.
• W4360804105 cites W2136059996 @default.
• W4360804105 cites W2140709510 @default.
• W4360804105 cites W2144893470 @default.
• W4360804105 cites W2150971584 @default.
• W4360804105 cites W2151898393 @default.
• W4360804105 cites W2158103813 @default.
• W4360804105 cites W2266629023 @default.
• W4360804105 cites W2398319251 @default.
• W4360804105 cites W2412329778 @default.
• W4360804105 cites W2412707497 @default.
• W4360804105 cites W2514306162 @default.
• W4360804105 cites W2514405894 @default.
• W4360804105 cites W2516346419 @default.
• W4360804105 cites W2622265102 @default.
• W4360804105 cites W2734565754 @default.
• W4360804105 cites W2739087236 @default.
• W4360804105 cites W2766744941 @default.
• W4360804105 cites W2775735370 @default.
• W4360804105 cites W2810041660 @default.
• W4360804105 cites W2884215306 @default.
• W4360804105 cites W2885977543 @default.
• W4360804105 cites W2887705421 @default.
• W4360804105 cites W2888212375 @default.
• W4360804105 cites W2892016825 @default.
• W4360804105 cites W2905250717 @default.
• W4360804105 cites W2982898340 @default.
• W4360804105 cites W2990985235 @default.
• W4360804105 cites W2997717105 @default.
• W4360804105 cites W3003524341 @default.
• W4360804105 cites W3041078929 @default.
• W4360804105 cites W3092074931 @default.
• W4360804105 cites W3100827664 @default.
• W4360804105 cites W3201979636 @default.
• W4360804105 cites W37436426 @default.
• W4360804105 doi "https://doi.org/10.1007/s10238-023-01033-0" @default.
• W4360804105 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36961677" @default.
• W4360804105 hasPublicationYear "2023" @default.
• W4360804105 type Work @default.
• W4360804105 citedByCount "3" @default.
• W4360804105 countsByYear W43608041052023 @default.
• W4360804105 crossrefType "journal-article" @default.
• W4360804105 hasAuthorship W4360804105A5005572572 @default.
• W4360804105 hasAuthorship W4360804105A5007704090 @default.
• W4360804105 hasAuthorship W4360804105A5008659449 @default.
• W4360804105 hasAuthorship W4360804105A5034054749 @default.
• W4360804105 hasAuthorship W4360804105A5034673563 @default.
• W4360804105 hasAuthorship W4360804105A5039733933 @default.
• W4360804105 hasAuthorship W4360804105A5043274812 @default.
• W4360804105 hasAuthorship W4360804105A5044462846 @default.
• W4360804105 hasAuthorship W4360804105A5053976378 @default.

• next